REG - Iconic Labs PLC - Adjournment to the GM

Iconic LabsAnnouncement

26/11/2021 10:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211126:nRSZ6303Ta&default-theme=true

RNS Number : 6303T  Iconic Labs PLC  25 November 2021

For immediate release

ICONIC LABS PLC - IN ADMINISTRATION

The Joint Administrators provide the following update on the administration
and the adjournment of General Meeting:

Headline: General Meeting Adjournment

The General Meeting ("GM") which had been convened for 2.00pm on Tuesday 15
June 2021 and which was adjourned until Tuesday 23 November 2021 has been
further adjourned to 2.00 p.m. on Tuesday, 30 November 2021 to be held at the
offices of KWM Europe LLP, being the 9th Floor, 24 Monument Street, London
EC3R 8AJ or such other place as is notified to shareholders.

 

Proxies that have been submitted for the GM will remain valid for the
adjourned GM and you do not need to submit a new proxy unless you wish to
change how your proxy should vote. However, you may continue to submit a proxy
form for the GM up to 2.00pm on Friday 26 November 2021. Proxy forms must be
submitted in accordance with the instructions set out in the notice of meeting
dated 20 May 2021.

 

The GM is expected to take place on 30 November 2021 with no further
adjournment, except in exceptional circumstances.

 

Progress of the Administration

CVA Proposals

The Board report that detailed discussions are progressing between the Board,
EHGOSF and Arch, the Secured Creditor, with a view to a "Global Settlement"
being agreed. If agreement is reached, CVA proposals will be put to creditors
and members.

All parties are aware of the urgency for an agreement to be reached.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCMZMZMFKGGMZM